 |
인쇄하기
취소
|
Merck Korea to launch anti-diabetic drug "Glucophage XR"
Merck Korea, a subsidiary of German Merck, announced the market launching plan for an anti-diabetic drug called "Glucophage XR sustained tablet" in April, which was a sustained metformin tablet taking once 4 tablets (2000mg) a day in maximum.
Merck Korea said that the new tablet showed 24 hours blood sugar control activity by slowly releasing metformin in the body and therefore improved pat...
Merck Korea said that the new tablet showed 24 hours blood sugar control activity by slowly releasing metformin in the body and therefore improved pat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.